Allspring Global Investments’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-112
Closed -$9.08K 2374
2023
Q4
$9.08K Sell
112
-370
-77% -$30.1K ﹤0.01% 2029
2023
Q3
$78.7K Sell
482
-25,669
-98% -$6.06M ﹤0.01% 2096
2023
Q2
$8.58M Buy
26,151
+1,972
+8% +$601K 0.01% 833
2023
Q1
$6.67M Buy
24,179
+4,888
+25% +$1.79M 0.01% 912
2022
Q4
$7.47M Sell
19,291
-39,922
-67% -$11.3M 0.01% 863
2022
Q3
$14.1M Sell
59,213
-39,830
-40% -$10.7M 0.03% 659
2022
Q2
$22.1M Sell
99,043
-36,906
-27% -$15.9M 0.04% 562
2022
Q1
$92.6M Buy
135,949
+1,571
+1% +$945K 0.12% 229
2021
Q4
$92.9M Buy
+134,378
New +$99.4M 0.1% 265

Other funds holding OM

Allspring Global Investments's OM Position: Q1 2024 in Review

Allspring Global Investments sold out of Outset Medical (OM) in Q1 2024, closing a stake of 112 shares — an estimated $9.08K sold.

Allspring Global Investments first reported a position in OM in Q4 2021 and held it in 9 quarters. The position peaked at $92.9M in Q4 2021. 114 funds tracked by Wall St. Rank hold OM as of Q1 2024.

  • Allspring Global Investments reported no remaining Outset Medical position as of Q1 2024 after selling out during the quarter.
  • Allspring Global Investments sold 112 Outset Medical shares in Q1 2024, an estimated $9.08K.
  • Allspring Global Investments first reported a position in Outset Medical in Q4 2021 and held it in 9 quarters.
  • Allspring Global Investments's Outset Medical position peaked at $92.9M in Q4 2021.
  • 114 funds tracked by Wall St. Rank held Outset Medical as of Q1 2024.

Based on Allspring Global Investments's 13F filing for Q1 2024, filed 18 Apr 2024.